What Is Lupin 500 Used For and How Does It Work?

Lupin 500 is a 500 mg tablet of cefuroxime axetil, a prescription antibiotic manufactured by Lupin Pharmaceuticals. Cefuroxime axetil is the oral form of cefuroxime, a second-generation cephalosporin antibiotic that kills a broad range of bacteria by disrupting their cell walls. Doctors prescribe it for respiratory tract infections, sinusitis, urinary tract infections, skin infections, ear infections, and early Lyme disease. Understanding what conditions it treats, how it compares to alternatives, and what to watch out for while taking it can help you get the most from a course of treatment.

How Cefuroxime Axetil Works Inside the Body

Cefuroxime axetil is actually a prodrug. When you swallow the tablet, your body converts it into active cefuroxime during absorption through the intestinal wall. Once in the bloodstream, cefuroxime targets the machinery bacteria use to build and maintain their cell walls. Specifically, it binds to proteins called penicillin-binding proteins on the bacterial surface, blocking the final steps of cell wall assembly. Without a functional cell wall, the bacteria swell and burst.

What made cefuroxime stand out when it was first developed is its resistance to many bacterial enzymes called beta-lactamases. Some bacteria produce these enzymes to chew up antibiotics before they can do any damage, which is why older penicillins and first-generation cephalosporins sometimes fail. Cefuroxime’s chemical structure is harder for those enzymes to break down, so it remains effective against many strains that have developed resistance to simpler antibiotics. In laboratory testing, it inhibited beta-lactamase-producing strains of common pathogens including Haemophilus influenzae and Neisseria gonorrhoeae, and it showed strong activity against members of the Enterobacteriaceae family, with all Salmonella and Klebsiella isolates susceptible at standard concentrations.¹ It is effective against a wide variety of infections caused by both gram-positive and gram-negative bacteria, though it has no meaningful activity against Pseudomonas aeruginosa or Bacteroides fragilis.²

Dosing studies have confirmed that the 500 mg tablet taken twice daily achieves drug levels in the blood that stay above the minimum needed to kill most target bacteria for a sufficient percentage of the dosing interval. This pharmacokinetic target is a key predictor of whether the antibiotic will work in real patients, and the 500 mg dose clears the bar for the susceptibility breakpoints set by European antimicrobial testing committees for the pathogens it is designed to treat.³

Conditions Lupin 500 Is Prescribed For

Cefuroxime axetil 500 mg covers a wide range of common bacterial infections. Your doctor may prescribe it for any of the following, depending on the suspected pathogen and local resistance patterns.

Sinus Infections

Acute bacterial sinusitis is one of the most frequent reasons cefuroxime axetil is prescribed. In a randomized trial of over 260 patients with confirmed acute bacterial maxillary sinusitis, cefuroxime axetil 250 mg twice daily was as effective as amoxicillin/clavulanate taken three times daily, with equivalent clinical success rates at both end-of-treatment and follow-up visits.⁴ For chronic sinusitis or acute flare-ups of chronic sinusitis, higher doses of 500 mg twice daily are sometimes used. In one trial comparing that dose to amoxicillin/clavulanate in over 200 adults with chronic sinusitis, clinical cure rates were similar at around 88% to 95%, though relapse after treatment was somewhat higher in the cefuroxime group.⁵

Bronchitis Flare-Ups

When chronic bronchitis flares up with a bacterial component, cefuroxime axetil is a standard treatment option. A double-blind trial in 376 patients with acute exacerbations of chronic bronchitis found that 500 mg twice daily for ten days produced clinical cure in about 83% of evaluable patients.⁶ A separate trial comparing a five-day course of cefuroxime axetil 250 mg twice daily against ten days of amoxicillin/clavulanate for secondary bacterial infections of acute bronchitis showed similar efficacy between the two, with satisfactory outcomes in about 86% of cefuroxime-treated patients.⁷

Urinary Tract Infections

Cefuroxime axetil is used for uncomplicated urinary tract infections, particularly when first-line options are unsuitable. A real-world study at a large academic medical center found clinical cure rates of about 98% for UTIs treated with cefuroxime, which was comparable to another oral cephalosporin, cefpodoxime.⁸

Skin and Soft Tissue Infections

For common skin infections like cellulitis, wound infections, and abscesses, cefuroxime axetil is effective. A study assessing a seven-day course of 250 mg twice daily in 97 patients with various skin and soft tissue infections found overall clinical improvement in 95% of cases, regardless of the specific type of infection being treated.⁹ A separate trial comparing 250 mg and 500 mg doses found beneficial outcomes in over 90% of patients at both dose levels, with no significant advantage to the higher dose for routine skin infections.¹⁰

Lyme Disease

Early Lyme disease, marked by the characteristic expanding rash, is another important indication. In a randomized trial of 232 patients, cefuroxime axetil 500 mg twice daily for 20 days produced a satisfactory clinical outcome in 90% of evaluable patients, compared to 95% for doxycycline. The difference was not statistically significant, and cefuroxime axetil was equally effective at preventing the later stages of Lyme disease from developing.¹¹ This makes it a particularly useful option for people who cannot take doxycycline, such as pregnant women and young children.¹²

Ear Infections in Children

Cefuroxime axetil is also used for acute otitis media in children. A trial in 55 children aged 5 to 10 found that cefuroxime axetil 250 mg every 12 hours for 10 days achieved a cure rate of about 74%, with clinical improvement in essentially all remaining patients. This was comparable to standard amoxicillin dosing, with no clinical failures in either group.¹³

Why You Should Always Take It With Food

This is one of the most practical things to know about cefuroxime axetil, and a point many people miss. Because the drug is a prodrug that needs to be absorbed through the gut before it becomes active, anything that improves absorption improves how well it works. Taking it on an empty stomach results in only about 36% of the dose being absorbed, while taking it right after a meal bumps absorption up to roughly 50% or more. Peak blood levels are about 43% higher after a fed dose compared to a fasting dose.¹⁴ A second study confirmed this pattern, finding bioavailability of about 41% to 45% when taken with food, and recommended that patients always take doses shortly after eating.¹⁵

Skipping a meal before your dose isn’t just mildly inconvenient. It could mean the difference between drug levels that clear the threshold needed to kill bacteria and levels that fall short, especially for organisms at the upper edge of susceptibility. If you’re taking Lupin 500 for a serious infection, this is not a detail to overlook.

How It Compares to Other Common Antibiotics

Cefuroxime axetil occupies a middle ground in the antibiotic toolkit. It generally matches amoxicillin/clavulanate in effectiveness for sinusitis and bronchitis, but it tends to cause fewer gastrointestinal side effects. In the acute sinusitis trial mentioned earlier, drug-related adverse events occurred in 17% of cefuroxime patients compared to 29% of those on amoxicillin/clavulanate, with diarrhea being the main driver of the difference.⁴ In the acute bronchitis trial, the gap was even wider: gastrointestinal side effects hit 23% of amoxicillin/clavulanate patients but only 4% of those taking cefuroxime axetil.⁷

Against fluoroquinolones like levofloxacin, cefuroxime axetil is generally competitive but not always equal. A large double-blind trial comparing the two for bronchitis exacerbations found per-protocol cure rates of about 66% for cefuroxime axetil versus 78% to 79% for levofloxacin.¹⁶ That said, fluoroquinolones carry their own set of serious safety concerns, including tendon damage and nerve problems, which is why many guidelines now reserve them for situations where safer alternatives have failed.

Side Effects to Watch For

Most people tolerate cefuroxime axetil well. The most common complaints are gastrointestinal: nausea, diarrhea, and stomach discomfort. As the comparative data above show, these effects tend to be milder and less frequent than with amoxicillin/clavulanate, which contains clavulanic acid, a known irritant to the gut.

There is, however, a more serious concern with cefuroxime and gut health. Like many cephalosporins and broad-spectrum antibiotics, cefuroxime can disrupt the normal bacteria in your intestines and allow Clostridioides difficile to take hold, causing severe diarrhea. In one hospital-based study, cefuroxime was among the antibiotics most commonly associated with C. difficile-associated diarrhea.¹⁷ A separate study found the incidence of this complication was about 9% among hospitalized patients treated with cefuroxime for lower respiratory infections, compared to roughly 2% for those receiving levofloxacin.¹⁸ This risk is highest in hospitalized patients and older adults, and it is much lower in otherwise healthy outpatients taking a short course at home. Still, if you develop watery diarrhea that persists or worsens during or after a course of Lupin 500, you should contact your doctor.

Allergic Reactions

Cefuroxime is a cephalosporin, and like all cephalosporins, it can trigger allergic reactions in a small number of people. Immediate allergic reactions to cephalosporins occur in roughly 1% to 3% of the population, while true anaphylaxis is extremely rare, estimated at 0.0001% to 0.1%.¹⁹

A common question is whether people with a penicillin allergy can safely take cefuroxime. The two drug families share some chemical features, and cross-reactivity is possible, particularly when the cephalosporin’s side chain structure resembles that of the penicillin that caused the original reaction. Cefuroxime has a different R1 side chain from amoxicillin, which is the penicillin most people react to. A UK retrospective study found that among 154 patients labeled as penicillin-allergic who received a cephalosporin with a side chain similar to amoxicillin, none developed an allergic reaction, including 35 whose index reaction was specifically to amoxicillin.²⁰ The practical upshot is that true cross-reactivity rates are lower than many people (and some older reference materials) suggest, but if you have a confirmed severe penicillin allergy, your doctor should evaluate the specific drugs involved before prescribing a cephalosporin.

Kidney Function and Dose Adjustments

Cefuroxime is eliminated almost entirely by the kidneys. In people with normal kidney function, essentially 100% of the drug is recovered in the urine within 24 hours, and the half-life in the blood is short, around 1.7 hours.²¹ As kidney function declines, the drug hangs around longer. In people with mild to moderate kidney impairment, the half-life roughly doubles to about 2.4 hours, and in those with severe impairment it can stretch to nearly 17 hours.²²

In patients on dialysis for acute renal failure, the half-life was measured at about 12.6 hours, with the drug being cleared partly by the dialysis machine and partly by whatever residual kidney function remains.²³ Doctors will typically adjust the dose or the interval between doses for patients with significantly reduced kidney function to prevent the drug from accumulating to unnecessarily high levels. If you have kidney disease, make sure your prescriber knows your most recent kidney function tests before starting this medication.

Use During Pregnancy

Infections during pregnancy sometimes require antibiotics, and the safety profile of the chosen drug matters enormously. Cefuroxime axetil has a relatively reassuring track record in this regard. A prospective cohort study that followed women exposed to cefuroxime during the first trimester found that rates of major birth defects in the cefuroxime group (about 3.2%) did not differ significantly from the general population reference rate (about 2%). Rates of spontaneous miscarriage and other pregnancy outcomes were also comparable between exposed and unexposed women.²⁴

An 18-month follow-up study tracked the physical and mental development of infants born to mothers who received cefuroxime axetil during pregnancy. No developmental abnormalities attributable to the drug were identified, which adds clinical support for its use when a pregnant woman needs an antibiotic and older first-line agents face resistance concerns.²⁵ These studies are small, and the confidence intervals are wide, so the evidence is reassuring rather than definitive. But cefuroxime axetil is generally considered one of the safer antibiotic options when treatment is needed during pregnancy.

How Bacteria Develop Resistance to Cefuroxime

No antibiotic works forever, and resistance is a real issue for cefuroxime. The two main routes bacteria use to dodge it are enzyme production and target modification. Some bacteria produce extended-spectrum beta-lactamases that can break down cefuroxime despite its designed resistance to simpler enzymes. Others alter the penicillin-binding proteins that cefuroxime targets, making it harder for the drug to latch on.

Research using molecular simulations has illustrated how even small mutations in penicillin-binding proteins can drastically reduce a drug’s ability to bind. In one study comparing a drug-sensitive and a drug-resistant strain of Streptococcus suis, the resistant strain’s penicillin-binding protein formed only one unstable bond with cefuroxime, compared to three stable bonds in the sensitive strain. Key amino acid mutations at just three positions in the protein were responsible for the difference.²⁶ This kind of finding underscores why antibiotic stewardship matters: every unnecessary course of a cephalosporin gives bacteria more opportunities to develop and select for these resistance mutations.

In practical terms, resistance rates to cefuroxime vary by region and by pathogen. Your doctor should be aware of local resistance patterns when deciding whether cefuroxime axetil is the right choice for your infection. If a culture and sensitivity test has been done, those results will guide the decision directly. Taking the full prescribed course, at the right dose, and with food, gives the drug the best chance of clearing the infection completely and leaving fewer survivors to develop resistance.